Aoxing Pharmaceutical Company Inc
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiq… Read more
Aoxing Pharmaceutical Company Inc (AOXG) - Net Assets
Latest net assets as of March 2017: $18.09 Million USD
Based on the latest financial reports, Aoxing Pharmaceutical Company Inc (AOXG) has net assets worth $18.09 Million USD as of March 2017.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($62.47 Million) and total liabilities ($44.38 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $18.09 Million |
| % of Total Assets | 28.95% |
| Annual Growth Rate | 7.09% |
| 5-Year Change | -15.0% |
| 10-Year Change | 47.77% |
| Growth Volatility | 84.0 |
Aoxing Pharmaceutical Company Inc - Net Assets Trend (2001–2016)
This chart illustrates how Aoxing Pharmaceutical Company Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Aoxing Pharmaceutical Company Inc (2001–2016)
The table below shows the annual net assets of Aoxing Pharmaceutical Company Inc from 2001 to 2016.
| Year | Net Assets | Change |
|---|---|---|
| 2016-06-30 | $18.08 Million | +79.63% |
| 2015-06-30 | $10.06 Million | +351.03% |
| 2014-06-30 | $-4.01 Million | -187.46% |
| 2013-06-30 | $4.58 Million | -78.45% |
| 2012-06-30 | $21.27 Million | -44.51% |
| 2011-06-30 | $38.32 Million | +11.71% |
| 2010-06-30 | $34.31 Million | +39.24% |
| 2009-06-30 | $24.64 Million | -2.08% |
| 2008-06-30 | $25.16 Million | +105.70% |
| 2007-06-30 | $12.23 Million | +170.73% |
| 2006-06-30 | $4.52 Million | -11.18% |
| 2005-06-30 | $5.09 Million | -6.02% |
| 2003-06-30 | $5.41 Million | -15.42% |
| 2002-06-30 | $6.40 Million | -1.05% |
| 2001-06-30 | $6.47 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Aoxing Pharmaceutical Company Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5629374500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2016)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $76.21K | 0.40% |
| Other Comprehensive Income | $1.72 Million | 9.01% |
| Other Components | $73.63 Million | 384.77% |
| Total Equity | $19.14 Million | 100.00% |
Aoxing Pharmaceutical Company Inc Competitors by Market Cap
The table below lists competitors of Aoxing Pharmaceutical Company Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD
|
$369.58K |
|
Mühlbauer Holding AG
XETRA:MUB
|
$369.66K |
|
Global Bioenergies SA
F:1DK
|
$369.68K |
|
BANK OF THE OZARKS
BE:BO8
|
$369.71K |
|
Ready Set Gold Corp
PINK:RDYFF
|
$369.35K |
|
Hydrocarbon Dynamics Limited
PINK:PYMOF
|
$369.32K |
|
Birman Wood and Hardware Ltd
TA:BIRM
|
$369.22K |
|
Janus Electric Holdings Ltd
AU:JNS
|
$369.09K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aoxing Pharmaceutical Company Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2015 to 2016, total equity changed from 11,238,147 to 19,135,955, a change of 7,897,808 (70.3%).
- Net income of 2,061,000 contributed positively to equity growth.
- Share repurchases of 2,739,000 reduced equity.
- Other comprehensive income decreased equity by 1,342,286.
- Other factors increased equity by 9,918,094.
Equity Change Factors (2015 to 2016)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $2.06 Million | +10.77% |
| Share Repurchases | $2.74 Million | -14.31% |
| Other Comprehensive Income | $-1.34 Million | -7.01% |
| Other Changes | $9.92 Million | +51.83% |
| Total Change | $- | 70.28% |
Book Value vs Market Value Analysis
This analysis compares Aoxing Pharmaceutical Company Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.03x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2001-06-30 | $38.37 | $0.01 | x |
| 2002-06-30 | $34.74 | $0.01 | x |
| 2005-06-30 | $20.59 | $0.01 | x |
| 2006-06-30 | $0.23 | $0.01 | x |
| 2007-06-30 | $0.61 | $0.01 | x |
| 2008-06-30 | $1.02 | $0.01 | x |
| 2009-06-30 | $0.60 | $0.01 | x |
| 2010-06-30 | $0.76 | $0.01 | x |
| 2011-06-30 | $0.83 | $0.01 | x |
| 2012-06-30 | $0.44 | $0.01 | x |
| 2013-06-30 | $0.11 | $0.01 | x |
| 2014-06-30 | $-0.05 | $0.01 | x |
| 2015-06-30 | $0.18 | $0.01 | x |
| 2016-06-30 | $0.25 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aoxing Pharmaceutical Company Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 10.77%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.37%
- • Asset Turnover: 0.57x
- • Equity Multiplier: 2.94x
- Recent ROE (10.77%) is above the historical average (-28.98%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2001 | -9.09% | -41.12% | 0.18x | 1.23x | $-1.23 Million |
| 2002 | -0.78% | -4.45% | 0.14x | 1.22x | $-689.92K |
| 2005 | -4.68% | -19.88% | 0.21x | 1.13x | $-746.72K |
| 2006 | -33.48% | 0.00% | 0.00x | 3.98x | $-1.96 Million |
| 2007 | -31.72% | -200.10% | 0.06x | 2.51x | $-5.10 Million |
| 2008 | 14.51% | 51.62% | 0.13x | 2.23x | $1.13 Million |
| 2009 | -9.95% | -27.42% | 0.16x | 2.30x | $-4.92 Million |
| 2010 | -2.41% | -13.60% | 0.10x | 1.69x | $-4.29 Million |
| 2011 | -19.10% | -111.43% | 0.11x | 1.51x | $-11.29 Million |
| 2012 | -72.30% | -194.49% | 0.18x | 2.06x | $-18.01 Million |
| 2013 | -296.39% | -155.16% | 0.27x | 7.01x | $-17.37 Million |
| 2014 | 0.00% | -64.49% | 0.33x | 0.00x | $-7.97 Million |
| 2015 | 48.90% | 21.57% | 0.48x | 4.72x | $4.37 Million |
| 2016 | 10.77% | 6.37% | 0.57x | 2.94x | $147.40K |
Industry Comparison
This section compares Aoxing Pharmaceutical Company Inc's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $-56,363,212
- Average return on equity (ROE) among peers: -7.18%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aoxing Pharmaceutical Company Inc (AOXG) | $18.09 Million | -9.09% | 2.45x | $369.49K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $-22.04K | 0.00% | 0.00x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $5.32 Million | -71.85% | 3.84x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $-185.37K | 0.00% | 0.00x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-181.19K | 0.00% | 0.00x | $14.73K |
| ACRO Biomedical Co Ltd (ACBM) | $-14.79K | 0.00% | 0.00x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-1.02K | 0.00% | 0.00x | $3.15K |